HBV

This early-stage study tests a new drug, Tune-401, in 36 adults with chronic hepatitis B who are already on standard antiviral therapy. The main goal is to check the drug's safety and how the body processes it. Researchers hope Tune-401 may help control the virus better, but this…

This study evaluates a new point-of-care test called MagIA H3S that can detect HIV, hepatitis B, hepatitis C, and syphilis from a single blood sample. Researchers will test about 2,950 people in Ivory Coast and Kenya to see how accurate the device is compared to standard lab test…

This study aims to create a fast T-cell analysis test to help doctors better manage chronic hepatitis B and B/D infections. Researchers will observe 300 patients over time, linking immune responses to disease outcomes. No new treatments are tested; the goal is to improve monitori…

This study follows 490 immunocompromised patients with past hepatitis B infection who are taking antiviral drugs to prevent the virus from reactivating. Researchers will monitor bone, kidney, and metabolic health over 4 years to understand long-term side effects. The goal is to c…

This study tracks 20 adults with chronic hepatitis delta (a serious liver infection) who are starting a new drug called bulevirtide. Researchers want to see how the drug changes the gut's bacteria and bile acids over 48 weeks, and how those changes relate to inflammation and live…